Flores Julio, García-Avello Angel, Flores Victor M, Navarro José L, Canseco Felipe, Pérez-Rodríguez Esteban
Servicio de Neumología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Arch Pathol Lab Med. 2003 Mar;127(3):310-5. doi: 10.5858/2003-127-0310-TPAPLA.
Pulmonary embolism (PE) is a potentially fatal and frequent complication of deep venous thrombosis, and the most reliable techniques for the diagnosis of PE are not universally available and have other limitations.
To determine the efficacy of 4 different fibrinolysis system parameters, namely, tissue plasminogen activator (tPA), tissue plasminogen activator inhibitor type 1 (PAI-1), plasmin-antiplasmin complexes (PAP), and D-dimer, in the diagnosis of acute PE.
A 350-bed university hospital serving an area with 280,000 inhabitants.
Sixty-six consecutive outpatients with clinically suspected PE. The diagnosis of PE was based on ventilation-perfusion (V/Q) lung scan in combination with clinical assessment, lower limb study, and (when required) pulmonary angiography.
At the moment of clinical suspicion, a sample of venous blood was obtained to measure levels of tPA, PAI-1, PAP, and D-dimer using an enzyme-linked immunosorbent assay method.
Twenty-seven patients (41%) were classified as PE positive (high clinical probability and V/Q lung scan [n = 12], nondiagnostic V/Q lung scan and high clinical probability [n = 1], inconclusive V/Q lung scan and positive lower limb examination for deep venous thrombosis [n = 11], and positive pulmonary angiography [n = 3]), and 39 patients (59%) were classified PE negative. The sensitivity/negative predictive value for tPA, using a cutoff of 8.5 ng/mL, and PAI-1, using a cutoff of 15 ng/mL, were 100%/100% and 100%/100%, respectively. A tPA level lower than 8.5 ng/mL occurred in 13 (19.7%; all PE negative) of 66 patients with suspected PE, and PAI-1 levels were lower than 15 ng/mL in 9 (13.6%; all PE negative) of 66 patients with suspected PE. The D-dimer, using a cutoff of 500 ng/mL, showed a sensitivity and negative predictive value of 92.6% and 87.5%, respectively.
Our data indicate that tPA and PAI-1 levels are potentially useful in ruling out PE, although tPA seems to be the better parameter. The sensitivity levels and negative predictive values for the rapid enzyme-linked immunosorbent assay for D-dimer used in this investigation were low compared with previous studies using the same test.
肺栓塞(PE)是深静脉血栓形成的一种潜在致命且常见的并发症,而诊断PE最可靠的技术并非普遍可用且存在其他局限性。
确定4种不同的纤溶系统参数,即组织型纤溶酶原激活物(tPA)、1型组织型纤溶酶原激活物抑制剂(PAI-1)、纤溶酶-抗纤溶酶复合物(PAP)和D-二聚体,在急性PE诊断中的效能。
一家拥有350张床位、服务于一个有28万居民地区的大学医院。
66例临床疑似PE的连续门诊患者。PE的诊断基于通气-灌注(V/Q)肺扫描并结合临床评估、下肢检查以及(必要时)肺血管造影。
在临床怀疑时,采集静脉血样本,采用酶联免疫吸附测定法测量tPA、PAI-1、PAP和D-二聚体水平。
27例患者(41%)被分类为PE阳性(高临床概率且V/Q肺扫描[n = 12]、V/Q肺扫描未确诊且高临床概率[n = 1]、V/Q肺扫描不确定且下肢深静脉血栓检查阳性[n = 11]以及肺血管造影阳性[n = 3]),39例患者(59%)被分类为PE阴性。tPA以8.5 ng/mL为临界值时的敏感性/阴性预测值以及PAI-1以15 ng/mL为临界值时的敏感性/阴性预测值分别为100%/100%和100%/100%。在66例疑似PE患者中,13例(19.7%;均为PE阴性)的tPA水平低于8.5 ng/mL,9例(13.6%;均为PE阴性)的PAI-1水平低于15 ng/mL。D-二聚体以500 ng/mL为临界值时,敏感性和阴性预测值分别为92.6%和87.5%。
我们的数据表明,tPA和PAI-1水平在排除PE方面可能有用,尽管tPA似乎是更好的参数。与此前使用相同检测方法的研究相比,本研究中用于D-二聚体的快速酶联免疫吸附测定法的敏感性水平和阴性预测值较低。